BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B
BiohacksAI/Targets/MYLK4/Compounds

Compounds That Target MYLK4

myosin light chain kinase family member 4 · 14 compounds in BiohacksAI corpus

MYLK4 (myosin light chain kinase family member 4) is a biological target with 14 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into MYLK4 modulation for therapeutic and biohacking applications.

View MYLK4 target page →UniProt: Q86YV6 ↗
All 14 Compounds — Ranked by Evidence
1
Tozasertib
4.33
confidence
2
Midostaurin
3.85
confidence
3
Nintedanib
3.61
confidence
4
Bms 387032
3.47
confidence
5
Fedratinib
3.40
confidence
6
Dovitinib
3.09
confidence
7
Lestaurtinib
3.04
confidence
8
R 406
2.83
confidence
9
Plx 4720
2.71
confidence
10
Bms 345541
2.71
confidence
11
Kw 2449
2.64
confidence
12
Su 014813
2.20
confidence
13
Enzastaurin
2.08
confidence
14
Pictilisibdrugage
0.69
confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for MYLK4 (myosin light chain kinase family member 4). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: MYLK4 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.